Format

Send to

Choose Destination
J Dermatol. 2019 Jan 23. doi: 10.1111/1346-8138.14786. [Epub ahead of print]

Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapy.

Author information

1
Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
PMID:
30672615
DOI:
10.1111/1346-8138.14786

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center